v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 266.6 $ 289.2
Trade and other accounts receivable (less allowances of $9.4 million and $11.9 million respectively) 336.1 341.7
Inventories (less allowances of $37.7 million and $34.6 million respectively):    
Finished goods 235.2 197.9
Raw materials 101.6 103.1
Total inventories 336.8 301.0
Prepaid expenses 13.7 21.0
Prepaid income taxes 12.1 3.1
Other current assets 4.4 0.6
Total current assets 969.7 956.6
Net property, plant and equipment 295.8 269.7
Operating lease right-of-use assets 49.3 44.8
Goodwill 397.6 382.5
Other intangible assets 78.3 65.4
Deferred tax assets 8.9 9.4
Pension asset 0.0 2.4
Other non-current assets 6.5 3.9
Total assets 1,806.1 1,734.7
Current liabilities:    
Accounts payable 149.4 163.8
Accrued liabilities 163.5 169.1
Current portion of operating lease liabilities 15.6 13.9
Current portion of plant closure provisions 5.0 5.0
Accrued income taxes 3.9 19.6
Total current liabilities 337.4 371.4
Operating lease liabilities, net of current portion 33.7 31.0
Plant closure provisions, net of current portion 63.8 55.3
Deferred tax liabilities 24.0 23.5
Pension liabilities and post-employment benefits 13.9 13.1
Acquisition-related contingent consideration 24.5 20.1
Other non-current liabilities 7.3 4.2
Total liabilities 504.6 518.6
Equity:    
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares 0.3 0.3
Additional paid-in capital 372.7 369.9
Treasury stock (4,656,089 and 4,594,943 shares at cost, respectively) (104.7) (93.0)
Retained earnings 1,060.5 1,025.0
Accumulated other comprehensive loss (33.4) (91.0)
Total Innospec stockholders' equity 1,295.4 1,211.2
Non-controlling interest 6.1 4.9
Total equity 1,301.5 1,216.1
Total liabilities and equity $ 1,806.1 $ 1,734.7